Nanobiotix
NBTX
24.62
-0.61
-2.42%
Nanobiotix
US · NBTX
#3096 by market cap
Listed 2020
24.62
-0.61
-2.42%
Live - 5344 symbols - heartbeat 118s ago
· 2026-10-08 05:24
Pre-market
23.72
-3.65%
After-hours
24.62
0.00%
Overnight
24.06
-2.27%
- Market cap
- 1.25B
- P/E (TTM)i
- -20.18
- P/Bi
- -33.54
- EPSi
- -0.56
- Div yieldi
- 0.00%
- 52W posi
- 23%
Reader sentiment
Are you bullish or bearish on NBTX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.45, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +355.35% YoY
Margins
- Operating margin
- -36.49%
- Net margin
- -80.83%
Key ratios & quality
- Enterprise valuei
- 1.29B
- Altman Z-Scorei
- 4.45
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 116.00K | 68.00K | 50.00K | 2.65M | 0 | 30.06M | -11.61M | 29.64M |
| Gross profit | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 12.62M | 18.64M | 14.27M | 19.02M | 17.48M | 21.66M | 20.06M | 20.22M |
| Research & development | 20.89M | 30.41M | 24.33M | 30.38M | 32.64M | 38.40M | 40.54M | 23.12M |
| Operating profit | -30.07M | -46.78M | -36.43M | -52.58M | -46.70M | -26.78M | -68.39M | -10.82M |
| Pretax profit | -30.35M | -50.91M | -33.58M | -47.00M | -57.03M | -39.58M | -68.03M | -23.96M |
| Tax | 0 | 3.00K | 9.00K | 5.00K | 10.00K | 120.00K | 101.00K | 3.00K |
| Net profit | -30.35M | -50.91M | -33.59M | -47.00M | -57.04M | -39.70M | -68.13M | -23.96M |
| Basic EPS | -2 | -2 | -1 | -1 | -2 | -1 | -1 | -1 |
| Diluted EPS | -1.55 | -2.35 | -1.38 | -1.35 | -1.64 | -1.08 | -1.44 | -0.50 |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -- | -- | -- | -- | -- | -- |
| Pretax profit | -- | -- | -- | -- | -- | -- |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -- | -- | -- | -- | -- | -- |
| Basic EPS | -- | -- | -- | -- | -- | -- |
| Diluted EPS | -- | -- | -- | -- | -- | -- |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 42.65M | 46.13M | 125.25M | 93.06M | 52.36M | 87.34M | 61.47M | 62.75M |
| Cash & ST investments | 36.20M | 35.09M | 119.15M | 83.92M | 41.39M | 75.28M | 49.74M | 52.75M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 46.20M | 56.21M | 134.03M | 101.77M | 59.77M | 93.90M | 67.42M | 67.76M |
| Total current liabilities | 11.60M | 14.35M | 19.04M | 36.85M | 37.94M | 49.87M | 58.94M | 57.51M |
| Short-term debt | 500.00K | 1.09M | 4.87M | 8.20M | 4.56M | 5.02M | 4.92M | 4.31M |
| Long-term debt | 20.02M | 37.62M | 39.12M | 32.42M | 44.04M | 41.66M | 43.01M | 89.12M |
| Total liabilities | 31,952,000.00 | 58,114,000.00 | 63,562,000.00 | 74,978,000.00 | 86,814,000.00 | 95,741,000.00 | 133,121,000.00 | 152,243,000.00 |
| Total equity | 14.24M | -1.91M | 70.47M | 26.79M | -27.05M | -1.84M | -65.70M | -84.48M |
| Retained earnings | -30.35M | -50.92M | -33.59M | -47.00M | -57.04M | -39.70M | -68.13M | -23.96M |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 87.34M | 80.46M | 61.47M | 39.89M | 62.75M | 123.48M |
| Cash & ST investments | 75.28M | 66.34M | 49.74M | 28.82M | 52.75M | 110.89M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 93.90M | 86.68M | 67.42M | 45.17M | 67.76M | 128.33M |
| Total current liabilities | 49.87M | 56.52M | 58.94M | 63.04M | 57.51M | 85.93M |
| Short-term debt | 5.02M | 5.00M | 4.92M | 4.74M | 4.31M | 32.07M |
| Long-term debt | 41.66M | 40.73M | 43.01M | 44.12M | 89.12M | 73.28M |
| Total liabilities | 95,741,000.00 | 108,456,000.00 | 133,121,000.00 | 114,126,000.00 | 152,243,000.00 | 161,713,000.00 |
| Total equity | -1.84M | -21.78M | -65.70M | -68.95M | -84.48M | -33.38M |
| Retained earnings | -39.70M | -336.45M | -68.13M | -5.38M | -23.96M | -34.29M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -25.99M | -41.17M | -27.54M | -29.87M | -37.10M | -12.48M | -19.55M | -33.42M |
| Depreciation & amortization | 619.00K | 1.77M | 1.75M | 1.56M | 1.50M | 1.51M | 1.62M | 1.50M |
| Free cash flow | -26.49M | -42.61M | -27.65M | -30.11M | -37.20M | -12.81M | -20.40M | -33.97M |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock buybacks / issuance | 0 | 29.52M | 113.65M | 0 | 0 | 60.15M | 0 | 1.54M |
| Ending cash balance | 36.20M | 35.09M | 119.15M | 83.92M | 41.39M | 75.28M | 49.74M | 52.75M |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -- | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -- | -- | -- | -- | -- | -- |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | -- | -- | -- | -- | -- | -- |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -104.34 | -825.60 | -97.99 | -96.66 | -- | -- | -- | -- |
| ROA %i | -58.55 | -99.44 | -35.31 | -39.87 | -70.62 | -51.67 | -84.47 | -35.45 |
| ROIC %i | -70.81 | -119.48 | -46.81 | -48.20 | -- | -- | -- | -- |
| 5-year avg ROE %i | -90.66 | -244.37 | -249.15 | -241.97 | -- | -- | -- | -- |
| EBIT margin %i | -25,429.31 | -67,822.06 | -66,562.00 | -463,270.00 | -- | -105.12 | 516.37 | -45.75 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 3.68 | 3.22 | 6.58 | 2.53 | 1.38 | 1.75 | 1.04 | 1.09 |
| Quick ratioi | 3.58 | 3.03 | 6.46 | 2.47 | 1.30 | 1.70 | 0.99 | 1.05 |
| Debt / assetsi | 44.42 | 79.22 | 36.54 | 45.22 | 88.96 | 53.85 | 75.50 | 140.67 |
| LT debt / equityi | 140.57 | -- | 62.59 | 141.15 | -- | -- | -- | -- |
| Interest coveragei | -34.83 | -9.62 | -99.94 | -69.04 | -8.77 | -3.96 | -7.41 | -1.30 |
| Revenue CAGR (3Y) %i | -24.12 | -64.79 | -41.67 | -55.82 | -- | 743.98 | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | -51.67 | -52.68 | -84.47 | -78.33 | -35.45 | -60.94 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -105.12 | -69.53 | 516.37 | -603.90 | -45.75 | -384.63 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 1.75 | 1.42 | 1.04 | 0.63 | 1.09 | 1.44 |
| Quick ratioi | 1.70 | 1.38 | 0.99 | 0.60 | 1.05 | 1.40 |
| Debt / assetsi | 53.85 | 56.72 | 75.50 | 113.43 | 140.67 | 83.08 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | -3.96 | -3.14 | -7.41 | -5.10 | -1.30 | -1.55 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Services is the largest reported line at 76.52% of revenue, across 2 reported segments.
- The next-largest line, Other Sales, is a distant second at 23.48% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Services76.52%
Other Sales23.48%
Region
France100.00%
Quote time 2026-10-08 05:24:16 · For reference only, not investment advice and not tailored to your situation.